Literature DB >> 25025028

The paracholedochal vein: a feasible option as portal inflow in living donor liver transplantation.

Joo Dong Kim1, Dong Lak Choi1, Young Seok Han1.   

Abstract

Extensive thrombosis of the portal and splenomesenteric veins combined with cavernous transformation of the portal vein (CTPV) has been considered to be a contraindication for living donor liver transplantation (LDLT) due to technical difficulties and perioperative risks. In recent years, several surgical innovations including cavoportal hemitransposition, renoportal anastomosis, and portal arterialization have been introduced to overcome diffuse portal vein thrombosis (PVT) and CTPV, but their outcomes were unsatisfactory with significant morbidity and mortality. Herein, we report two successful cases of adult LDLT in diffuse PVT with CTPV managed using the paracholedochal vein as portal inflow to the graft.

Entities:  

Keywords:  Cavernous transformation of portal vein; Liver transplantation; Living donors

Year:  2014        PMID: 25025028      PMCID: PMC4091443          DOI: 10.4174/astr.2014.87.1.47

Source DB:  PubMed          Journal:  Ann Surg Treat Res        ISSN: 2288-6575            Impact factor:   1.859


INTRODUCTION

Portal vein thrombosis (PVT) with cavernous transformation of the portal vein (CTPV) represents a surgically demanding challenge in living donor liver transplantation (LDLT) [1]. Although various surgical techniques and approaches to PVT has been introduced to overcome PVT, the absence of portal flow remains a surgically demanding challenge in the setting of LDLT because it has an obvious influence on surgical complexity, morbidity and mortality rates [1,2,3]. Furthermore, portal vein (PV) reconstruction is a very difficult procedure in LDLT with extensive PVT with CTPV in the setting of decreasing portal hypertension and providing adequate portal inflow [3,4]. Therefore, most transplant surgeons have hesitated to perform LDLT in cases with diffuse PVT and CTPV [4,5]. Herein, we present two successful adult LDLT using paracholedochal veins as portal inflow in cases with diffuse PVT and CTPV.

SURGICAL TECHNIQUES

Case 1

A 63-year-old female patient with hepatitis B-related liver cirrhosis was transferred to Daegu Catholic University Medical Center because of refractory ascites and hepatic encephalopathy. Preoperative Doppler ultrasonography and multidimensional computed tomography (MDCT) revealed the diffuse PVT that extended to the superior mesenteric vein (SMV) and splenic vein. In addition, marked dilated paracholedochal veins around the PV were being fed from the gastroepiploic veins and pancreaticoduodenal veins (Fig. 1A). Mesenteric venography demonstrated several findings, including complete invisibility of the main PV and SMV and large tortuous paracholedochal veins that extended to the proximal SMV (Fig. 1B). The donor was her 59-year-old brother. The estimated graft volume of the donor's right lobe as calculated by CT volumetry was 798 mL, 63.7% of the whole liver and the estimated graft-to-recipient weight ratio (GRWR) was 1.42%. Therefore, LDLT using a modified right lobe graft from her younger brother was performed. After complete mobilization of the recipient's liver, hepatic hilar dissection was attempted. However, dissection of the vascular pedicle at the hilum was too difficult due to severe fibrosis and a complex network of tortuous paracholedochal varices. Thus, after dissection and ligation of the hepatic arteries were performed, the PV and bile duct were clamped and transected en masse. Dissection of the native PV revealed that it had no obvious lumen and was replaced by a fibrotic, thrombosed cord. We identified two collateral veins with large orifices around the bile duct and transformed these large dilated collaterals into a common orifice with a venoplasty at their confluence. Several small collaterals which were not suitable for portal inflow were ligated. After declamping of the hilum, we ensured that the blood flow was adequate for portal inflow by spurting through the common orifice. We carried out usual end-to-end anastomosis of the donor PV to the large common orifice formed by the confluence of the markedly dilated paracholedochal veins using a running suture of 6-0 prolene (Fig. 2A). The graft was reperfused after completion of the PV anastomosis followed by hepatic artery reconstruction using a microsurgical technique. Roux-en-Y hepaticojejunostomy was performed because of severe periductal fibrosis and a narrowed caliber that could not maintain bile flow for duct-to-duct anastomosis. Intraoperative Doppler assessment showed adequate portal blood flow to the graft, and the PV patency was demonstrated by regular Doppler monitoring and MDCT (Fig. 2B).
Fig. 1

(A) Preoperative CT showed diffuse portal vein thrombosis (arrow) extended to superior mesenteric vein (SMV) and marked dilated paracholedochal veins (arrowhead). (B) Schematic illustration of cavernous transformation of the portal vein found at CT and mesenteric venography showed large tortuous paracholedochal collaterals (arrows) and complete invisibility of main portal vein and proximal SMV due to thrombosis. PV, portal vein; SV, splenic vein; GEV, gastroepiploic vein.

Fig. 2

(A) End-to-end portal anastomosis was constructed between the graft and common cloaca formed by the confluence of paracholedochal veins (arrowhead). (B) Good portal vein patency to the graft (arrow) was demonstrated by dynamic computed tomography on the 14th postoperative day.

The patient was discharged 3 weeks postoperatively without any complications and has been doing well for 22 months with normal graft function.

Case 2

A 51-year-old man was admitted with massive ascites and general weakness due to alcoholic liver cirrhosis. Preoperative Doppler ultrasonography and MDCT demonstrated several dilated paracholedochal veins along hilum and diffuse PVT extended to SMV like the first case. The donor was his 30-year-old son. The preoperative CT volumetry demonstrated the estimated right to left lobe volumes to be 966 mL and 500 mL (65.9% and 34.1% in volume ratio) and the estimated GRWR was 1.19%. Thus, we planned to perform LDLT using a modified right lobe graft from his son. During the operation, we found chronic organized PVT with dilated paracholedochal collaterals along porta hepatis. The transected PV showed no venous flow; it contained chronic totally organized thrombi with fibrosis. Even though we tried to eversion thrombectomy, it was failed to obtain sufficient portal inflow to the graft. Unfortunately, the caliber of these collaterals was smaller than that of case 1 and venous flow through common orifice with venoplasty from their confluence was not sufficient for portal inflow. Because another approach to gain splanchnic inflow could not be available, we performed unification venoplasty with common colaca from paracholedochal veins and partially recanalized naitive PV to supplement unsatisfactory inflow through paracholedochal collaterals. This complex common orifice was anastomosed to the donor PV in end-to-end fashion as a single anastomosis (Fig. 3A). Hepatic artery and bile duct reconstruction was performed by the same method as case 1.
Fig. 3

(A) The complex common orifice formed by venoplasty from paracholedochal collaterals and native portal vein was anastomosed to the donor portal vein (arrowhead). (B) Serial postoperative Doppler studies demonstrated satisfactory portal vein flow to the graft.

Intraoperative Doppler ultrasonography showed satisfactory portal blood flow in the liver graft and the good PV patency was demonstrated by serial postoperative Doppler studies(Fig. 3B) and MDCT. He was discharged without any serious complication and has remained stable without ascites, variceal bleeding for 21 months after transplantation.

DISCUSSION

In the early period of liver transplantation, PVT was considered to be a contraindication for the procedure because of the technical difficulties it entailed, especially the inability to gain an adequate portal supply [6]. However, several surgical techniques have been developed for deceased donor liver transplantation (DDLT), such as thrombectomy, interposition or a jump graft between the donor and recipient PV, cavoportal hemitransposition (CPHT), renoportal anastomosis (RPA), and PV arterializations [1,2]. With these surgical innovations, the results of DDLT for patients with PVT have been comparable to those of patients without PVT [1,6]. In spite of recent reports that described excellent outcomes in LDLT, several difficulties are associated with performance of these surgical innovations for pre-existing PVT in the setting of LDLT, such as the necessity of distal dissection of the vascular pedicle of the hilum, restricted availability of deceased donor vein grafts, and ethical concerns of the living donor [7]. Moreover, LDLT is still considered a surgically demanding challenge in the case of an extended PVT including the SMV with CTPV because this procedure is associated with perioperative morbidity and mortality as a result of rethrombosis and increased blood loss [8]. In 1986, Hiatt et al. [9] reported the first successful DDLT using a thin-walled bile duct varix as the inflow to the donor PV, and various alternatives were subsequently reported to overcome PVT with CTPV, such as CPHT, RPA, and portal arterializations [2,3]. In the present case, we planned to perform PV reconstruction using large dilated paracholedochal veins because it was demonstrated that these collaterals could provide the adequate portal inflow to the graft in preoperative MDCT and mesenteric venography. This technique offers some advantages over other surgical options using systemic blood flow as portal inflow. The advantages include the followings: (1) In PV reconstruction such as RPA, CPHT causes loss of hepatotrophic factors provided by PV inflow, which is believed to be essential for hepatic regeneration [2]. (2) In patients undergoing RPA and CPHT, persistent portal hypertension has been described with ascites, renal dysfunction, variceal bleeding, and hepatic encephalopathy [2,3]. (3) The long-term effects of PV inflow with systemic venous flow remain unknown [2]. Finally, (4) less vascular dissection is required and the operating time is decreased to a jump graft from the SMV to PV of the graft [10]. However, this technique, as mentioned above, also has disadvantages; e.g., using collateral veins to reconstruct the portal flow may increase the incidence of vascular complications such as thrombosis [1,10].

CONCLUSION

The use of a recipient's enlarged paracholedochal veins as a splanchnic venous supply into the graft can be a feasible option in cases with diffuse PVT and CTPV during LDLT.
  10 in total

1.  Portal revascularization in the setting of cavernous transformation through a paracholedocal vein: a case report.

Authors:  F Rotellar; J A Cienfuegos; A Bueno; P Martí; V Valentí; G Zozaya; F Pardo
Journal:  Transplant Proc       Date:  2010-10       Impact factor: 1.066

2.  Salvage procedure for unexpected portal vein thrombosis in living donor liver transplantation.

Authors:  D Maluf; I Shim; M Posner; A H Cotterell; R A Fisher
Journal:  Transplant Proc       Date:  2006-06       Impact factor: 1.066

3.  Bile duct varices. An alternative to portoportal anastomosis in liver transplantation.

Authors:  J R Hiatt; W J Quinones-Baldrich; K P Ramming; J F Lois; R W Busuttil
Journal:  Transplantation       Date:  1986-07       Impact factor: 4.939

Review 4.  Surgical strategies for liver transplantation in the case of portal vein thrombosis--current role of cavoportal hemitransposition and renoportal anastomosis.

Authors:  Marius Paskonis; Jonas Jurgaitis; Arianeb Mehrabi; Arash Kashfi; Hamidreza Fonouni; Kestutis Strupas; Markus W Büchler; Thomas W Kraus
Journal:  Clin Transplant       Date:  2006 Sep-Oct       Impact factor: 2.863

5.  [Living-related liver transplantation for cavernous transformation of portal vein: a clinical study of 3 cases].

Authors:  Ming-man Zhang; Xian-qing Jin; Lü-nan Yan; Quan Kang; Chun-bao Guo
Journal:  Zhonghua Gan Zang Bing Za Zhi       Date:  2008-04

6.  Application of cryopreserved vein grafts as a conduit between the coronary vein and liver graft to reconstruct portal flow in adult living liver transplantation.

Authors:  Tsung-Han Wu; Hong-Shiue Chou; Kuang-Tse Pan; Ching-Song Lee; Ting-Jun Wu; Sung-Yu Chu; Miin-Fu Chen; Wei-Chen Lee
Journal:  Clin Transplant       Date:  2009-07-31       Impact factor: 2.863

7.  Thrombosis confined to the portal vein is not a contraindication for living donor liver transplantation.

Authors:  Jai Young Cho; Kyung-Suk Suh; Woo Young Shin; Hae Won Lee; Nam-Joon Yi; Kuhn Uk Lee
Journal:  World J Surg       Date:  2008-08       Impact factor: 3.352

8.  Liver transplant recipients with portal vein thrombosis: a single center retrospective study.

Authors:  Yi-Feng Tao; Fei Teng; Zheng-Xin Wang; Wen-Yuan Guo; Xiao-Min Shi; Gui-Hua Wang; Guo-Shan Ding; Zhi-Ren Fu
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2009-02

9.  Cavernous transformation of portal vein: 16-slice CT portography and correlation with surgical procedure of orthotopic liver transplantation.

Authors:  Long-Jiang Zhang; Gui-fen Yang; Bin Jiang; Lian-qing Wen; Wen Shen; Ji Qi
Journal:  Abdom Imaging       Date:  2008 Sep-Oct

10.  Adult to pediatric living donor liver transplantation for portal cavernoma.

Authors:  Mingman Zhang; Chunbao Guo; Conglun Pu; Zhimei Ren; Yingcun Li; Quan Kang; Xianqing Jin; Lvnan Yan
Journal:  Hepatol Res       Date:  2009-05-07       Impact factor: 4.288

  10 in total
  3 in total

1.  De novo malignancy after liver transplantation: a single-center experience of 14 cases.

Authors:  Peng Ji Gao; Jie Gao; Zhao Li; Zhi Ping Hu; Ji Ye Zhu
Journal:  Ann Surg Treat Res       Date:  2015-03-26       Impact factor: 1.859

Review 2.  Optimal Treatment for Patients With Cavernous Transformation of the Portal Vein.

Authors:  Bo Wei; Zhiyin Huang; Chengwei Tang
Journal:  Front Med (Lausanne)       Date:  2022-03-24

3.  Portal vein-variceal anastomosis for portal vein inflow reconstruction in orthotopic liver transplantation: A case report and review of literature.

Authors:  Aviad Gravetz
Journal:  World J Transplant       Date:  2022-07-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.